Yuna is from Seoul, South Korea. She received her B.S. in Bio-Convergence and completed her M.S. studies in Immunology at Yonsei University. After completing her degree, she worked at the Korea Drug Development Fund, a government-funded organization established to support new drug development and commercialization for Korean pharmaceutical and biotechnology companies. In this role, she was involved in global partnering and business development initiatives. She then worked for two years as a Life Sciences and Healthcare consultant at EY, where she supported multiple projects for leading Korean biotech companies and global pharmaceutical clients. In addition to her work in the biotech and pharmaceutical sectors, she also gained experience across a wide range of industries, including financial holding companies and semiconductor companies, completing more than ten strategic consulting projects across diverse sectors.
ykim0624@usc.edu
Guillermo is a first-generation student at the University of Southern California, pursuing a Master of Public Administration. Rooted in Boyle Heights and South Central, he loves working at the intersection of data, policy, and strategic communications, building tools and strategies for Public Facing Organizations. His work spans from GIS frameworks that informed $700M in Prop 4 climate investment decisions for LA County, a decade of Medicare cost analysis at the USC Schaeffer Center for Health Policy and Economics, and communications and analytics strategy for some of LA's most visible public agencies as a Strategic Communications Intern at Lee Andrews Group.
gmc70251@usc.edu
Anna Tung is currently a Ph.D. candidate in Biomedical Engineering at USC, where her research focuses on AI applications in sleep medicine. She earned her B.E. in Engineering Science and M.S. in Biomedical Electronics and Bioinformatics from National Taiwan University.
During her master's studies, Anna founded a dental X-ray medical device startup and secured $100K in angel investment. After graduation, she joined Texas Instruments as a Technical Sales Engineer, managing a $20 million customer portfolio and driving 25% year-over-year revenue growth. She is also an Analyst at the USC Marshall Venture Fund, evaluating early-stage technology and healthcare startups. Her experiences across entrepreneurship, industry, and venture investing have shaped her interest in strategy, innovation, and technology commercialization.
naiyun@usc.edu
Yi-Chuan is a Ph.D. student in Epidemiology with a research focus on identifying modifiable risk factors for gastrointestinal cancers using population-level data. Beyond epidemiology, he has a strong interest in economics, investing, Federal Reserve monetary policy, and financial markets. He is an avid follower of Warren Buffett and Charlie Munger and enjoys applying their principles of rational decision-making and long-term thinking. As the Director of Finance at ADCC, Yi-Chuan aims to combine his scientific training with his passion for economics and finance to support the organization’s mission.
yuyichua@usc.edu
https://www.linkedin.com/in/yi-chuan-yu-336774115/?skipRedirect=true
Meghan is a second-year Master of Public Policy student at USC, with a focus in data science and analytics. Her consulting experience includes participating in the ESG Dilemma Design Challenge Consulting Project through the University of Michigan’s Erb Institute and a Pro Bono Business Strategy Consulting Project held through the Advanced Degree Consulting Club (ADCC), where she helped project ~$18.6K in annual profit growth. Now serving as the Director of Programming of ADCC, she is thrilled to plan more events and panel discussions to help fellow graduate students learn more about consulting as a career.
mljacob@usc.edu
https://www.linkedin.com/in/meghan-jacob-01b000240/
Cecilia Zhang is currently pursuing her Ph.D. in Biomedical Engineering and M.S. in Engineering Management at the University of Southern California. She received her B.S. in Biochemistry with a minor in Japanese and completed her M.S. in Bioengineering at UCLA. Before beginning her Ph.D., she worked at the UCSF Cell Design Institute, where she developed CAR-T cell therapies focused on improving target specificity, and at Quantapore, a biotech startup, where she supported technology development for a nanopore-based sequencing platform. She also gained venture capital experience at Morningside 5Y, evaluating biotech startups in point-of-care diagnostics and commercialization potential. In addition to her research and industry experience, Cecilia has held leadership roles in academic and student organizations, including serving as Multimedia Chair for the 2026 Fred S. Grodins Biomedical Engineering Symposium.
hanxuzha@usc.edu
